| 1. |
Palareti G, Cosmi B, Antonucci E, et al. Duration of anticoagulation after isolated pulmonary embolism. Eur Respir J, 2016, 47(5): 1429-1435.
|
| 2. |
Paik B, Joh JH, Park HC. Anatomic and clinical risk factors for pulmonary embolism in patients with deep venous thrombosis of the lower extremity. Ann Surg Treat Res, 2017, 92(5): 365-369.
|
| 3. |
Yoo HHB, Marin FL. Isolated subsegmental pulmonary embolism: current therapeutic challenges. Pol Arch Intern Med, 2020, 130(11): 986-991.
|
| 4. |
乌兰, 党永康, 杨柳. 下肢深静脉血栓抗凝药物研究进展. 血管与腔内血管外科杂志, 2017, 3(3): 795-799.
|
| 5. |
Mallorie A, Chan K, Ioannidis S. A case series of outcomes in isolated subsegmental pulmonary embolism on ventilation-perfusion imaging. Nucl Med Commun, 2018, 39(7): 618-620.
|
| 6. |
Moores LK. Are we overtreating isolated subsegmental pulmonary embolism? First Do No Harm. JAMA Intern Med, 2018, 178(9): 1274-1275.
|
| 7. |
Wu AR, Garry J, Labropoulos N. Incidence of pulmonary embolism in patients with isolated calf deep vein thrombosis. J Vasc Surg Venous Lymphat Disord, 2017, 5: 274-279.
|
| 8. |
Palareti G, Antonucci E, Dentali F, et al. Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution. Eur J Intern Med, 2019, 69: 64-70.
|
| 9. |
Dalia T, Ranka S, Patel N. Clinical presentation and outcomes of patients with isolated subsegmental pulmonary embolism: a tertiary care center experience. Vasc Med, 2020, 25(5): 468-470.
|
| 10. |
范浩亮. 凝血因子VLeiden、凝血酶原G2021A和血栓调节蛋白基因c. 1418C>T多态性及D-二聚体、纤维蛋白降解产物等生化指标与下肢深静脉血栓形成的相互关系研究. 山西: 山西医科大学, 2016. 1-54.
|
| 11. |
Stoller N, Limacher A, Méan M. Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism. Thromb Res, 2019, 184: 24-30.
|
| 12. |
Ząbczyk M, Natorska J, Janion-Sadowska A. Loose fibrin clot structure and increased susceptibility to lysis characterize patients with central acute pulmonary embolism: the impact of isolated embolism. Thromb Haemost, 2021, 121(4): 529-537.
|
| 13. |
Ten Cate V, Prochaska JH, Schulz A, et al. Protein expression profiling suggests relevance of noncanonical pathways in isolated pulmonary embolism. Blood, 2021, 137(19): 2681-2693.
|
| 14. |
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart, 2014, 35(43): 3033-3069.
|
| 15. |
Merli GJ. Pathophysiology of venous thrombosis and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly. Cardiol Clin, 2008, 26(2): 203-219.
|
| 16. |
Johnson SA, Eleazer GP, Rondina MT. Pathogenesis, diagnosis, and treatment of venous thromboembolism in older adults. Am Geriatr Soc, 2016, 64(9): 1869-1878.
|
| 17. |
Mohebali D, Kaplan D, Carlisle M, et al. Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults. Am Geriatr Soc, 2014, 62(3): 529-535.
|
| 18. |
Lee HY, Song IS, Yoo SM. Rarity of isolated pulmonary embolism and acute aortic syndrome occurring outside of the field of view of dedicated coronary CT angiography. Acta Radiol, 2011, 52(4): 378-384.
|
| 19. |
Blanco-Molina A, Monreal M. Venous thromboembolism in women taking hormonal contraceptives. Expert Rev Cardiovasc Ther, 2010, 8(2): 211-215.
|
| 20. |
Raynal PA, Cachanado M, Truchot J, et al. Prevalence of pulmonary embolism in emergency department patients with isolated syncope: a prospective cohort study. Eur J Emerg Med, 2019, 26(6): 458-461.
|
| 21. |
Corral J, Roldan V, Vicente V. Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox. Haematologica, 2010, 95(6): 863-866.
|
| 22. |
Li YP, Shang Y, Wang WW, et al. Lung cancer and pulmonary embolism: what is the relationship? A Review. Cancer, 2018, 9(17): 3046-3057.
|
| 23. |
Ye R, Zhao L, Wang CH, et al. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir Med, 2014, 108(1): 1-8.
|
| 24. |
Yan M, Kieser R, Wu CC. Clinical factors and outcomes of subsegmental pulmonary embolism in cancer patients. Blood Adv, 2021, 5(4): 1050-1058.
|
| 25. |
Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr, 2018, 6: 142.
|
| 26. |
Lee YH, Cha SI, Shin KM, et al. Clinical characteristics and outcomes of patients with isolated pulmonary embolism. Blood Coagul Fibrinolysis, 2021, 32(6): 387-393.
|
| 27. |
Gupta A, Pandya V, Baran T. Risk of pulmonary embolism in patients with isolated great saphenous vein thrombus. Ultrasound Q, 2018, 34(3): 167-169.
|
| 28. |
Baumgartner C, Klok FA, Carrier M, et al. Clinical Surveillance vs. Anticoagulation for low-risk patients with isolated subsegmental pulmonary embolism: protocol for a multicentre randomised placebo-controlled non-inferiority rial (SAFE-SSPE). BMJ Open, 2020, 10(11): e040151.
|
1/5
WeChat